NCT06204952View on ClinicalTrials.gov

Effectiveness of Joins® for Managing Lumbar Facetogenic Pain

NANot yet recruitingINTERVENTIONAL
Enrollment

76

Participants

Timeline

Start Date

June 22, 2024

Primary Completion Date

January 20, 2026

Study Completion Date

April 20, 2026

Conditions
Facet Joint Syndrome
Interventions
DRUG

Joins®(Clematidis Radix,Trichosanthes Root,Prunella Spike Extract)

In patients with facet joint syndrome, Joins® (Clematidis Radix, Trichosanthes Root, Prunella Spike Extract) is administered at a dosage of 1 tablet three times a day for 12 weeks.

DRUG

Placebo

In patients with facet joint syndrome, placebo drug is administered at a dosage of 1 tablet three times a day for 12 weeks.

All Listed Sponsors
lead

Jeeyoun Moon

OTHER

NCT06204952 - Effectiveness of Joins® for Managing Lumbar Facetogenic Pain | Biotech Hunter | Biotech Hunter